Bio/Pharmaceutical Outsourcing Report – Special DCAT 2016 Edition

by

PharmSource has published a special DCAT Edition of our proprietary industry briefing, Bio/Pharmaceutical Outsourcing Report.

This monthly report reports on and analyzes major developments throughout the CMO industry. It provides expert insight into the significance of industry trends and what they mean for your business.

Deepen your understanding of what’s happening in commercial and clinical dose manufacturing and packaging, API small and large molecule, captive capacity, regulatory developments and more.

Get your copy from the PharmSource team at DCAT. Or click here to download your complimentary copy.
 

Join us for DCAT’s 2016 Pharma Industry Outlook

PharmSource is pleased to be the program partner for this important DCAT session, which will be held Monday afternoon at 1:15 pm in the Waldorf Astoria’s Empire Room.
 

Pharmaceutical Outsourcing CMO Outlook

PharmSource president, Jim Miller, will give an overview of the contract dose manufacturing market at the Pharmaceutical Outsourcing CMO Outlook program at DCAT 2016.

Date: Tuesday, March 15, 2016
Time: 9:15 – 11:45 AM
Location: Empire Room, Waldorf Astoria Hotel, NYC

Related posts:
Trial Registrations Steady, Uptick Expected
Charles River Acquires WIL Research, May Target CTM Manufacture
Macro Matters

Katie Ludwick is PharmSource’s Marketing Manager. A graduate of George Mason University, she holds a BA degree in Communication with a concentration in Public Relations. In addition to having operational marketing responsibilities, Katie oversees list management and handles production for our monthly e-zine publications PharmSource Periscope and CMC Market Outlook.

More posts by Katie Ludwick